Evidence map›Paper›PMID 30074064›Full record

ArticlePsychopharmacology2019

Dissociation between hypothermia and neurotoxicity caused by mephedrone and methcathinone in TPH2 knockout mice.

John H Anneken, Mariana Angoa-Perez, Girish C Sati, David Crich, Donald M Kuhn

Abstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

John H AnnekenResearch & Development Service, John D. Dingell VA Medical Center, R&D Service (11R), 4646 John R, Detroit, MI, 48201, USA.
Mariana Angoa-PerezResearch & Development Service, John D. Dingell VA Medical Center, R&D Service (11R), 4646 John R, Detroit, MI, 48201, USA.
Girish C SatiDepartment of Chemistry, Wayne State University, Detroit, MI, 48201, USA.
David CrichDepartment of Chemistry, Wayne State University, Detroit, MI, 48201, USA.
Donald M KuhnResearch & Development Service, John D. Dingell VA Medical Center, R&D Service (11R), 4646 John R, Detroit, MI, 48201, USA. donald.kuhn@wayne.edu.ORCID http://orcid.org/0000-0002-8546-9507
Wayne State University · US

Funding

National Institute on Drug Abuse DA0396671
6 · The paper itself

Abstract

rationaleMephedrone is a commonly abused constituent of "bath salts" and has many pharmacological effects in common with methamphetamine. Despite their structural similarity, mephedrone differs significantly from methamphetamine in its effects on core body temperature and dopamine nerve endings. The reasons for these differences remain unclear.

objectivesMephedrone elicits a transient hypothermia which may provide intrinsic neuroprotection against methamphetamine-like toxicity to dopamine nerve endings. Furthermore, evidence in the literature suggests that this hypothermia is mediated by serotonin. By utilizing transgenic mice devoid of brain serotonin, we determined the contribution of this neurotransmitter to changes in core body temperature as well as its possible role in protecting against neurotoxicity. The effects of methcathinone and 4-methyl-methamphetamine, two structural analogs of mephedrone and methamphetamine, were also evaluated in these mice.

resultsThe hypothermia induced by mephedrone and methcathinone in wild-type mice was not observed in mice lacking brain serotonin. Despite preventing drug-induced hypothermia, the lack of serotonin did not alter the neurotoxic profiles of the test drugs.

conclusionsSerotonin is a key mediator of pharmacological hypothermia induced by mephedrone and methcathinone, but these body temperature effects do not contribute to dopamine nerve ending damage observed in mice following treatment with mephedrone, methcathinone or 4-methyl-methamphetamine. Thus, the key component of methamphetamine neurotoxicity lacking in mephedrone remains to be elucidated.

Indexed as

AnimalsFemaleHypothermiaIllicit DrugsMethamphetamineMiceMice, Inbred C57BLMice, KnockoutNerve EndingsNeurotoxicity SyndromesPropiophenonesTryptophan HydroxylaseIllicit DrugsmephedroneMethamphetaminemonomethylpropionPropiophenonesTph2 protein, mouseTryptophan Hydroxylase4-methyl-methamphetamineDopamineHypothermiaMephedroneMethcathinoneNeurotoxicity

Identifiers

PMID30074064
OpenAlexW2887253746

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.